industry knowledge and experience

The biopharma industry is rapidly evolving. Drug developers need future-focused partners to stay ahead of the curve.

Ambit’s consulting practices offer cutting-edge expertise in rare and specialty disease, empowering the biopharma industry to deliver innovative therapies and win as the market continues to evolve.
Seamlessly move from strategy to execution with a consulting partner that can provide holistic support and operationalize strategic insights. With decades of biopharma industry knowledge and experience, we provide hands-on senior leadership and project teams optimized for your needs.

Our consultants partner with clients to help them fully realize and communicate the value of their innovative assets to all stakeholders: healthcare providers, patients, and payers. We work primarily in specialty therapeutic categories, with a heavy focus on rare diseases.

Focused Expertise

Current state assessment informed by deep biopharma industry knowledge and experience


Strategic planning with a focus on landscape trends


Detailed roadmap-planning with a pragmatic mindset

Data-Driven Results

Accountable KPI measurement and monitoring

learn more

Contact us to learn more about how we can help you win as the market continues to evolve.

Join the strategy team

Meet the strategy team

Aileen Nicoletti directs our Strategy practice. With 20 years of experience in pre-commercial biotech strategy and launch preparation, she has the strategic and scientific expertise to deliver quality insights and strategies well supported by deep market understanding. She cares deeply about building a culture at Ambit that provides the best work for the client and maximizes development of the team.
Aileen Nicoletti
Managing Director
Allie has more than 8 years of experience in engineering and life sciences. Her drive to tackle seemingly unsolvable problems began during her PhD where she developed and patented novel biomaterials to treat spinal cord injury. She took this passion into her career in consulting where she found her niche in rare diseases where few, if any, treatments exist. During her time as a commercial strategy consultant, she gained therapeutic area acumen in rare diseases across gastroenterology, oncology, neurology, and immunology. She has considerable experience executing primary market research and is energized by facilitating insightful discussions with experts and patients ‘on the ground.’ Having the opportunity to create lasting change for patients with high unmet need ‘gets her out of bed in the morning.
Allie Kolberg-Edelbrock

Senior Consultant

Alex has more than 6 years of life sciences research experience with a focus on virology and immunology. His desire to solve complex problems started during his PhD when he identified and described a novel pro-viral factor for flavivirus transmission found in mosquito saliva. Prior to joining Ambit, Alex completed his PhD work in Boston, MA during which he worked closely with several startup and early-stage life science companies. He conducted market research, developed corporate and commercial strategies, and built client-tailored business plans across multiple therapeutic areas. Alex holds a BS in chemistry from the University of North Carolina at Chapel Hill and a PhD in microbiology from Boston University. He currently resides in Chicago, IL and enjoys playing soccer and sailing.
Alex Gold


Charlotte brings an analytical mindset with specific regard to helping solve complex problems in rare disease with our academic partnerships. Her work reflects a deep passion towards understanding these rare diseases and how our research can accurately portray these findings. Prior to joining Ambit, Charlotte completed her thesis on occupational safety in the industrial sector using augmented reality. She conducted market research and deep machine learning models to understand the current situation and provide recommendations to improve safety. Charlotte holds a BS in Exercise Science & Psychology from High Point University and MPH from George Washington University. She currently resides in Philadelphia, PA and enjoys ice skating and reading.
Charlotte Kramer


Dani brings more than 7 years of experience in strategic collaboration and innovative data-driven solutions to her engagements. She enjoys proposing creative solutions to optimize our clients’ ways of working. Dani’s background in applied economics, data analytics and HEOR have allowed her to pursue a number of professional opportunities, including public health consulting, policy advisory and HEOR modeling in international settings. Dani is committed to helping Ambit grow, supporting recruiting and business development efforts and promoting internal professional development for her teams.
Dani Perea
Engagement Manager
Dylan brings 6+ years of life sciences research experience in diagnostic and therapeutic development with a focus on the CNS, with a PhD focused on the identification of molecular triggers in the pathogenesis of Alzheimer’s disease. Prior to joining Ambit, Dylan worked as the scientific lead at a biotech startup based on his PhD work in Seattle, WA. He managed employees across the production, diagnostic, and therapeutic areas of the company and helped to make strategic decisions directly with the executive team to optimize path to market and develop programs for FDA approval (IND, NDA, breakthrough diagnostic). Dylan holds a BS in chemical engineering from the University of Delaware, and a MS and PhD in molecular engineering/bioengineering from the University of Washington. He currently resides in Seattle, WA and enjoys hiking, skiing, and gardening.
Dylan Shea